`Tel: 571-272-7822
`
`Paper 23
`Entered: February 24, 2017
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REACTIVE SURFACES LTD., LLP,
`Petitioner,
`
`v.
`
`TOYOTA MOTOR CORPORATION,
`Patent Owner.
`
`Case IPR2016-01462
`Patent 8,324,295 B2
`
`Before CHRISTOPHER M. KAISER, JEFFREY W. ABRAHAM, and
`MICHELLE N. ANKENBRAND, Administrative Patent Judges.
`
`KAISER, Administrative Patent Judge.
`
`DECISION
`Request for Rehearing
`37 C.F.R. § 42.71(d)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-01462
`Patent 8,324,295 B2
`
`INTRODUCTION
`
`Reactive Surfaces Ltd., LLP (“Petitioner”) filed a Petition (Paper 1,
`
`“Pet.”) requesting inter partes review of claims 1–27 of U.S. Patent No.
`
`8,324,295 B2 (Ex. 1001, “the ’295 patent”). Toyota Motor Corporation
`
`(“Patent Owner”) filed a Preliminary Response (Paper 10, “Prelim. Resp.”).
`
`On February 9, 2017, we instituted trial to determine whether claims 1–9,
`
`13–20, and 22–27 are unpatentable as obvious. Paper 14 (“Dec.”); see Paper
`
`16 (correcting list of claims on which trial was instituted). We did not
`
`institute trial on claims 10–12 or 21, because we determined that Petitioner
`
`did not demonstrate “a reasonable likelihood that the petitioner would
`
`prevail with respect to” those claims, as required by 35 U.S.C. § 314(a).
`
`Dec. 18–19, 23–24. Petitioner now requests rehearing of our decision not to
`
`institute trial on claims 10–12 and 21. Paper 21 (“Request”).
`
`We will grant a request for rehearing of a petition decision if the
`
`requesting party demonstrates “an abuse of discretion” in the decision.
`
`37 C.F.R. § 42.71(c). However, we will grant a request for rehearing only if
`
`that party also “specifically identif[ies] . . . the place where each matter [that
`
`we misapprehended or overlooked] was previously addressed.” Id.
`
`§ 42.71(d). After considering Petitioner’s request for rehearing, our
`
`decision, and the evidence currently of record, we determine that Petitioner
`
`has not demonstrated an abuse of discretion. Accordingly, we deny the
`
`request for rehearing.
`
`ANALYSIS
`
`Claims 10–12 and 21 of the ’295 patent each recite a limitation
`
`requiring the presence of a UV absorber chosen from the following Markush
`
`group: “C7-9 ester of [3-2hbenzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-
`
`2
`
`
`
`IPR2016-01462
`Patent 8,324,295 B2
`
`hydroxyphenyl)]-propionic acid; 2-(2H-benzotriazol-2-yl)-4,6-
`
`ditertpentylphenol; 2-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)-
`
`6-(benzotriazol-2-yl)phenol; methyl 3-[3-(benzotriazol-2-yl)-5-tert-butyl-4-
`
`hydroxyphenyl]propanoate; or 2-(4-Benzoyl-3-hydroxyphenoxy)ethyl
`
`acrylate.” Ex. 1001, 24:3–10, 24:46–53. Petitioner argued in the Petition
`
`that these claims were obvious over the combination of McDaniel ’853 and
`
`Fritzsche in part because (1) Fritzsche teaches the use of a commercial
`
`product called Tinuvin 384, (2) Tinuvin 384 has “the same active chemical
`
`composition as” Tinuvin 384-2, and (3) an unspecified one of the members
`
`of the Markush group recited in claims 10–12 and 21 is Tinuvin 384-2. Pet.
`
`59–61. We found Petitioner’s arguments insufficient to show a reasonable
`
`likelihood that Petitioner would prevail in showing that the prior art teaches
`
`or suggests the use of one of the members of the Markush group. Dec. 18–
`
`19. Although we agreed that Petitioner had directed us to sufficient record
`
`evidence to support its arguments that Fritzsche taught the use of Tinuvin
`
`384 and that Tinuvin 384-2 was one of the members of the Markush group,
`
`we determined that Petitioner had not “identif[ied] sufficient record evidence
`
`to support its argument that Tinuvin 384 and Tinuvin 384-2 have the same
`
`active chemical composition.” Id.
`
`Petitioner now argues that we “overlooked evidence sufficiently
`
`identified in the Petition supporting [Petitioner’s] argument that Tinuvin 384
`
`and Tinuvin 384-2 have the same active chemical composition and that . . .
`
`this would have been known to a person of ordinary skill in the art.”
`
`Request 8–9. Specifically, Petitioner argues that we overlooked a citation in
`
`the Petition to evidence that establishes the chemical structure of Tinuvin
`
`384 and that we failed to compare this established chemical structure to the
`
`3
`
`
`
`IPR2016-01462
`Patent 8,324,295 B2
`
`chemical structure of Tinuvin 384-2. Id. at 6–8 (citing Pet. 51; Ex. 1010,
`
`79:13–14).
`
`We are not persuaded that we overlooked this evidence. Instead,
`
`Petitioner did not bear its burden to direct us to this evidence. Petitioner
`
`presented the relevant discussion of the asserted unpatentability of claims
`
`10–12 and 21 on pages 59–61 of the Petition. On these pages, Petitioner
`
`offered no support by citing Exhibit 1010, or any other record evidence, for
`
`its argument that “[a] POSITA will recognize that TINUVIN® 384 is well
`
`known to have the same active chemical composition as TINUVIN® 384-
`
`2.” Pet. 60. Petitioner argues now that, despite such failure to offer any
`
`support in the vicinity of its statement, the Board should have realized that
`
`Petitioner offered support for the statement nine pages earlier, on page 51 of
`
`the Petition. This argument fails to recognize Petitioner’s burden to “specify
`
`where each element of the claim is found in the prior art patents or printed
`
`publications relied upon [to show unpatentability].” 37 C.F.R.
`
`§ 42.104(b)(4). It is Petitioner’s job, not the Board’s, to explain why the
`
`prior art renders the challenged claims unpatentable. Accordingly, the mere
`
`fact that the Petition made an argument and also offered some evidentiary
`
`support for that argument is, in the absence of any connection drawn in the
`
`Petition between the argument and the support, irrelevant to the question of
`
`whether the Board abused its discretion by overlooking the support.
`
`In any event, the “support” to which Petitioner now directs us is a
`
`string citation to 16 separate portions of Fritzsche, presented as support for
`
`the generic statement that Fritzsche “teaches . . . polymer resin, a surfactant,
`
`a non-aqueous organic solvent, a sterically hindered amine, and a UV
`
`absorber and a crosslinker to produce a curable material composition.” Pet.
`
`4
`
`
`
`IPR2016-01462
`Patent 8,324,295 B2
`
`51 (citing Ex. 1010, 77:27–28, 78:5–6, 77:34, 78:11, 77:30, 79:6, 78:13,
`
`79:5, 77:29, 78:8, 29:18–19, 30:19-20, 31:1–3, 77:29, 78:8, 79:13–14).
`
`Petitioner fails to explain why the Board should have recognized from the
`
`generic statement—which does not mention Tinuvin 384 or Tinuvin 384-2—
`
`that one of the 16 portions of the citation string might be relevant to the
`
`question of whether the two Tinuvin products have the same active chemical
`
`composition. When the Petition fails to explain the significance of certain
`
`record evidence, the Board does not abuse its discretion by failing to
`
`recognize the significance of that same evidence.
`
`CONCLUSION
`
`Upon consideration of Petitioner’s request for rehearing, our decision,
`
`and the evidence currently of record, we determine that Petitioner has not
`
`demonstrated an abuse of discretion in our decision. Accordingly, we deny
`
`the request for rehearing.
`
`
`
`It is hereby
`
`ORDER
`
`ORDERED that the request for rehearing is denied.
`
`
`
`
`
`
`
`5
`
`
`
`IPR2016-01462
`Patent 8,324,295 B2
`
`PETITIONER:
`
`David O. Simmons
`IVC PATENT AGENCY
`dsimmons@ivcpatentagency.com
`
`
`
`Jonathan D. Hurt
`MCDANIEL & ASSOCIATES, PC
`jhurt@technologylitigators.com
`
`
`
`Mark A.J. Fassold
`Jorge Mares
`WATTS GUERRA LLP
`mfassold@wattsguerra.comjmares@wattsguerra.com
`
`
`
`PATENT OWNER:
`
`Joshua A. Lorentz
`Richard Schabowsky
`John D. Luken
`Oleg Khariton
`DINSMORE & SHOHL LLP
`joshua.lorentz@dinsmore.comrichard.schabowsky@dinsmore.com
`
`
`
`
`
`6
`
`